cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

Schabel Fm, Trader Mw, Laster Wr, +2

PubMed

PathologyMetronomic ChemotherapyAdvanced P388Cancer ChemotherapyTumor Biology +15

Establishment of cross-resistance profiles for new agents.

Schabel Fm, Skipper He, Trader Mw, +3

PubMed

PathologyMetronomic ChemotherapyTumor BiologyDrug ResistanceHematological Malignancy +15

Concepts for controlling drug-resistant tumor cells.

Schabel Fm, Skipper He, Trader Mw, +3

PubMed

Drug-resistant Tumor CellsCancer Cell BiologyTumor TargetingAnti-cancer AgentTargeted Therapy +5

Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo.

Schabel Fm, Skipper He, Trader Mw, +1

PubMed

Leukemic Cell PopulationsOncologyExperimental EvaluationMedicineMetronomic Therapy +7

Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.

Corbett Th, Roberts Bj, Trader Mw, +3

PubMed

Transplantable TumorsOncologyPolymer-drug ConjugateMedicineImmunology +13

Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.

Skipper He, Schabel Fm, Trader Mw, +1

PubMed

Hematological MalignancyOncologyHematologyPathologyAk Leukemia +6

Spontaneous AK leukemia (lymphoma) as a model system.

Schabel Fm, Skipper He, Trader Mw, +2

PubMed

Hematological MalignancyTumor BiologyLymphoid NeoplasiaMedicineHematology +4

Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971.

Skipper He, Schabel Fm, Trader Mw, +3

PubMed

Hematological MalignancyTumor BiologySpontaneous Ak LymphomaLymphoid NeoplasiaMedicine +13

Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.

Griswold Dp, Trader Mw, Emil Frei, +3

PubMed

L1210 Leukemia ResistantImmunologyPharmacotherapyMetronomic ChemotherapyImmunotherapy +16

Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites.

Skipper He, Schabel Fm, Wilcox Ws, +3

PubMed

Hematological MalignancyOncologyExperimental EvaluationLeukemic CellsMedicine +9